Enhancer ID: | E_01_0440 |
Species: | human |
Position : | chr11:32385307-32387307 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Wilms tumor 1 (wt1) |
Pubmed ID: | 29851165 |
Enhancer experiment: | ChIP-seq,Quantitative methylation-specific PCR,Quantitative methylation-specific PCR,Western blot, |
Enhancer experiment description: | Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury. |
Target gene : | WT1(AWT1,GUD,NPHS4,WAGR,WIT-2,WT33) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury. |
TF name : | -- |
TF experiment: | ChIP-seq,Quantitative methylation-specific PCR,Quantitative methylation-specific PCR,Western blot, |
TF experiment description: | Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury. |
Enhancer function : | Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Our data suggest that the methylation pattern of the WT1 promoter and enhancers in human podocytes are distinctive from those in HK2. Furthermore, TGF-?1 alters the methylation levels of the WT1 promoter and enhancers in human podocytes. This modification may be relevant to the attenuation of WT1 by TGF-?1, which could contribute to podocyte injury. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|